Loading...

Aprea Therapeutics, Inc.

APRE•NASDAQ
Healthcare
Biotechnology
$0.94
$0.002(0.21%)
U.S. Market opens in 16h 39m

Aprea Therapeutics, Inc. (APRE) Stock Overview

Explore Aprea Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1M
P/E Ratio-0.58
EPS (TTM)$-1.93
ROE-0.94%
Fundamental Analysis

AI Price Forecasts

1 Month$0.32
3 Months$0.00
1 Year Target$0.00

APRE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aprea Therapeutics, Inc. (APRE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.58 and a market capitalization of 6.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.21%
5-Day Change
23.93%
1-Month Change
28.13%
3-Month Change
5.48%
6-Month Change
-36.71%
Year-to-Date (YTD) Change
10.55%
1-Year Change
-40.32%
3-Year Change
-76.72%
5-Year Change
-98.91%
All-Time (Max) Change
-99.77%

Contact Information

https://atrinpharma.com
617-463-9385
535 Boylston St., Boston, MA, 02116

Company Facts

8 Employees
IPO DateOct 3, 2019
CountryUS
Actively Trading

Frequently Asked Questions